PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
76677125 |
LAW OFFICE ASSIGNED |
LAW OFFICE 114 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ENDOTAG |
OWNER SECTION (no change) |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines
for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis,
breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas,
metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas,
astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis,
medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers,
hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies,
multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia,
coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a
coloscopy |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
4 |
ONGOING EFFORT |
steps to obtain required governmental approval |
ALLOWANCE MAIL DATE |
06/10/2008 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/adrienne white/ |
SIGNATORY'S NAME |
Adrienne L. White |
SIGNATORY'S POSITION |
Attorney of record, VA bar |
DATE SIGNED |
06/02/2010 |
FILING INFORMATION |
SUBMIT DATE |
Wed Jun 02 14:37:12 EDT 2010 |
TEAS STAMP |
USPTO/ESU-XX.XX.XXX.XXX-2
0100602143712343376-76677
125-4604efdd2fdd7fb756397
d7475d9d8b241f-DA-934-201
00602143319953618 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ENDOTAG
SERIAL NUMBER: 76677125
The applicant, MediGene AG, having an address of
Lochhamer Strasse 11
82152 Planegg/Martinsried, DE1
Germany
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 06/10/2008.
For International Class 005:
Current identification: Medicines for humans and animals in the form of serums and diagnostic preparations for medical purposes and therapeutic use, namely, medicines for treating tumorous diseases
such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain
cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers,
penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas,
neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic
cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas,
epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound
healing; medicines for treating eye diseases and arteriosclerosis; medicines for treating cardiovascular illnesses, namely, hyperlipidaemia, coronary heart diseases and cardiac insufficiency;
medicines for treating skin diseases, namely, warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: steps to obtain required governmental approval
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements may jeopardize the validity of the form or any resulting registration, declares that he/she is properly authorized to execute this form on behalf of the applicant; he/she believes the
applicant to be the owner of the trademark/service mark sought to be registered, or, if the form is being filed under 15 U.S.C. Section 1126(d) or (e), he/she believes applicant to be entitled to use
such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof
or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all
statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Signature: /adrienne white/ Date Signed: 06/02/2010
Signatory's Name: Adrienne L. White
Signatory's Position: Attorney of record, VA bar
RAM Sale Number: 934
RAM Accounting Date: 06/03/2010
Serial Number: 76677125
Internet Transmission Date: Wed Jun 02 14:37:12 EDT 2010
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2010060214371234
3376-76677125-4604efdd2fdd7fb756397d7475
d9d8b241f-DA-934-20100602143319953618